Continuation and maintenance treatments for persistent depressive disorder
Referencias
Additional references
Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, et al. Evidence‐based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology (Oxford, England) 2008;22(4):343‐96.
American Psychiatric Association (APA). Practice Guedlineline for the Treatment of Patients with Major Depressive Disorder. 3rd Edition. Washington, DC: American Psychiatric Association, 2010.
American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders (DSM‐5). 5th Edition. Washington, DC: American Psychiatric Association, 2013.
Arnow BA, Constantino MJ. Effectiveness of psychotherapy and combination treatment for chronic depression. Journal of Clinical Psychology 2003;59(8):893‐905.
Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory‐II. San Antonio, Texas: Psychological Corporation, 1996.
Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nature Reviews. Neuroscience 2006;7(2):137‐51.
Beshai S, Dobson KS, Bockting CL, Quigley L. Relapse and recurrence prevention in depression: current research and future prospects. Clinical Psychology Review 2011;31(8):1349‐60.
Bockting CL, Schene AH, Spinhoven P, Koeter MW, Wouters LF, Huyser J, et al. Preventing relapse/recurrence in recurrent depression with cognitive therapy: a randomized controlled trial. Journal of Consulting and Clinical Psychology 2005;73(4):647‐57.
Boland RJ, Keller MB. Course and outcome of depression. In: Gotlib IH, Hammen CL editor(s). Handbook of Depression. New York: Guilford Press, 2002:43‐60.
Browne G, Steiner M, Roberts J, Gafni A, Byrne C, Dunn E, et al. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6‐month comparison with longitudinal 2‐year follow‐up of effectiveness and costs. Journal of Affective Disorders 2002;68(2‐3):317‐30.
Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta‐analysis of randomized controlled trials. Journal of Clinical Epidemiology 1997;50(6):683‐91.
Cuijpers P, van Straten A, Schuurmans J, van OP, Hollon SD, Andersson G. Psychotherapy for chronic major depression and dysthymia: a meta‐analysis. Clinical Psychology Review 2010;30(1):51‐62.
Cuijpers P, Sijbrandij M, Koole SL, Andersson G, Beekman AT, Reynolds CF. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta‐analysis of direct comparisons. World Psychiatry 2013;12(2):137‐48.
Deeks JJ, Altman DG, Bradburn MJ. Chapter 15: Statistical methods for examining heterogeneity and combining results from several studies in meta‐analysis. In: Egger M, Smith GD, Altman DG editor(s). Systematic Reviews in Health Care: Meta‐Analysis in Context. 2nd Edition. London: BMJ Publishing Group, 2008:285‐312.
DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177‐88.
DGPPN, BÄK, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW (Editors) for the Guideline Group Unipolar Depression. S3‐Guideline/National Disease Management Guideline Unipolar Depression ‐ Long Version, 1st edition: Version 5. Available from www.leitlinien.de/mdb/downloads/nvl/depression/depression‐1aufl‐vers5‐lang.pdf (accessed 12 August 2015).
Dunner DL. Dysthymia and double depression. International Review of Psychiatry 2005;17(1):3‐8.
Epstein I, Szpindel I, Katzman MA. Pharmacological approaches to manage persistent symptoms of major depressive disorder: rationale and therapeutic strategies. Psychiatry Research 2014;220 Suppl 1:S15‐33.
Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Archives of General Psychiatry 1991;48(9):851‐5.
Gelenberg AJ, Trivedi MH, Rush AJ, Thase ME, Howland R, Klein DN, et al. Randomized, placebo‐controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression. Biological Psychiatry 2003;54(8):806‐17.
Gilmer WS, Trivedi MH, Rush AJ, Wisniewski SR, Luther J, Howland RH, et al. Factors associated with chronic depressive episodes: a preliminary report from the STAR‐D project. Acta Psychiatrica Scandinavica 2005;112(6):425‐33.
Glue P, Donovan MR, Kolluri S, Emir B. Meta‐analysis of relapse prevention antidepressant trials in depressive disorders. Australian and New Zealand Journal of Psychiatry 2010;44(8):697‐705.
Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383‐94.
Hamilton A. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960;23:56‐62.
Harrison W, Rabkin J, Stewart JW, McGrath PJ, Tricamo E, Quitkin F. Phenelzine for chronic depression: a study of continuation treatment. Journal of Clinical Psychiatry 1986;47(7):346‐9.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327(7414):557‐60.
Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Imel ZE, Malterer MB, McKay KM, Wampold BE. A meta‐analysis of psychotherapy and medication in unipolar depression and dysthymia. Journal of Affective Disorders 2008;110(3):197‐206.
Jarrett RB, Basco MR, Risser R, Ramanan J, Marwill M, Kraft D, et al. Is there a role for continuation phase cognitive therapy for depressed outpatients?. Journal of Consulting and Clinical Psychology 1998;66(6):1036‐40.
Jarrett RB, Kraft D, Doyle J, Foster BM, Eaves GG, Silver PC. Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial. Archives of General Psychiatry 2001;58(4):381‐8.
Jarrett RB, Minhajuddin A, Gershenfeld H, Friedman ES, Thase ME. Preventing depressive relapse and recurrence in higher‐risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo. JAMA Psychiatry 2013;70(11):1152‐60.
Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RM, et al. Time to recovery, chronicity, and levels of psychopathology in major depression. A 5‐year prospective follow‐up of 431 subjects. Archives of General Psychiatry 1992;49(10):809‐16.
Keller MB, Gelenberg AJ, Hirschfeld RM, Rush AJ, Thase ME, Kocsis JH, et al. The treatment of chronic depression, Part 2: A double‐blind, randomized trial of sertraline and imipramine. Journal of Clinical Psychiatry 1998;59(11):598‐607.
Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, et al. A comparison of nefazodone, the cognitive behavioral‐analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine 2000;342(20):1462‐70.
Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, et al. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2‐year and combined maintenance phases. Journal of Clinical Psychiatry 2007;68(8):1246‐56.
Kennedy SH, Lam RW, Parikh SV, Patten SB, Ravindran AV. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Journal of Affective Disorders 2009;117(Suppl 1):S1‐2.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age‐of‐onset distributions of DSM‐IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005;62(6):593‐602.
Kirsch I, Deacon BJ, Huedo‐Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta‐analysis of data submitted to the Food and Drug Administration. PLoS Medicine 2008;5(2):e45.
Klein DN, Santiago NJ, Vivian D, Blalock JA, Kocsis JH, Markowitz JC, et al. Cognitive‐behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression. Journal of Consulting and Clinical Psychology 2004;72(4):681‐8.
Klein DN. Chronic depression: diagnosis and classification. Current Directions in Psychological Science 2010;19(2):96‐100.
Klein JP, Steinlechner S, Sipos V, Schweiger U. Psychotherapie chronischer Depression nach dem Cognitive Behavioral Analysis System of Psychotherapy (CBASP)‐Konzept. Psychotherapie, Psychosomatik, Medizinische Psychologie 2011;61(12):526‐35.
Kocsis JH, Friedman RA, Markowitz JC, Leon AC, Miller NL, Gniwesch L, et al. Maintenance therapy for chronic depression. A controlled clinical trial of desipramine. Archives of General Psychiatry 1996;53(9):769‐74.
Kocsis JH, Rush AJ, Markowitz JC, Borian FE, Dunner DL, Koran LM, et al. Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. Psychopharmacology Bulletin 2003;37(4):73‐87.
Kocsis JH, Gelenberg AJ, Rothbaum B, Klein DN, Trivedi MH, Manber R, et al. Chronic forms of major depression are still undertreated in the 21st century: systematic assessment of 801 patients presenting for treatment. Journal of Affective Disorders 2008;110(1–2):55‐61.
Koran LM, Gelenberg AJ, Kornstein SG, Howland RH, Friedman RA, DeBattista C, et al. Sertraline versus imipramine to prevent relapse in chronic depression. Journal of Affective Disorders 2001;65(1):27‐36.
Kriston L, von Wolff A, Westphal A, Hölzel LP, Härter M. Efficacy and acceptability of acute treatments for persistent depressive disorder: a network meta‐analysis. Depression and Anxiety 2014;31(8):621‐30.
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry: the Journal of Mental Science 1979;134:382‐9.
MQ: Transforming mental health through research. Depression: asking the right questions. Project report. Identifying priorities for depression research. https://www.mqmentalhealth.org/articles/depression‐priority‐setting‐partnership (accessed 22 October 2017).
Murphy JA, Byrne GJ. Prevalence and correlates of the proposed DSM‐5 diagnosis of Chronic Depressive Disorder. Journal of Affective Disorders 2012;139(2):172‐80.
National Institute for Health & Clinical Excellence. Depression. The treatment and management of depression in adults (updated edition): National Clinical Practice Guideline 90. Leicester and London: British Psychological Society and the Royal College of Psychiatrists, 2010.
Nutt D, Demyttenaere K, Janka Z, Aarre T, Bourin M, Canonico PL, et al. The other face of depression, reduced positive affect: the role of catecholamines in causation and cure. Journal of Psychopharmacology (Oxford, England) 2007;21(5):461‐71.
Petersen TJ, Pava JA, Buchin J, Matthews JD, Papakostas GI, Nierenberg AA, et al. The role of cognitive‐behavioral therapy and fluoxetine in prevention of recurrence of major depressive disorder. Cognitive Therapy and Research 2010;34(1):13‐23.
Piet J, Hougaard E. The effect of mindfulness‐based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta‐analysis. Clinical Psychology Review 2011;31(6):1032‐40.
Pringle A, Browning M, Cowen PJ, Harmer CJ. A cognitive neuropsychological model of antidepressant drug action. Progress in Neuro‐psychopharmacology & Biological Psychiatry 2011;35(7):1586‐92.
Rabinowitz J, Werbeloff N, Mandel FS, Menard F, Marangell L, Kapur S. Initial depression severity and response to antidepressants v. placebo: patient‐level data analysis from 34 randomised controlled trials. British Journal of Psychiatry: the Journal of Mental Science 2016;209(5):427‐8.
Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rouillon F, Phillips R, Serrurier D, Ansart E, Gérard MJ. Prophylactic efficacy of maprotiline on relapses of unipolar depression [Rechutes de dépression unipolaire et efficacité de la maprotiline]. L'Encéphale: Revue de psychiatrie clinique biologique et thérapeutique 1989;15(6):527‐34.
Rush AJ, Carmody T, Reimitz P‐E. The Inventory of Depressive Symptomatology (IDS): Clinician (IDS‐C) and Self‐Report (IDS‐SR) ratings of depressive symptoms. International Journal of Methods in Psychiatric Research 2000;9(2):45‐59.
Segal ZV, Williams JMG, Teasdale JD. Mindfulness‐based Cognitive Therapy for Depression: a New Approach to Preventing Relapse. New York: Guilford, 2002.
Skevington SM, Lotfy M, O'Connell KA, WHOQOL Group. The World Health Organization's WHOQOL‐BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research: an international journal of quality of life aspects of treatment, care and rehabilitation 2004;13(2):299‐310.
Song F, Altman DG, Glenny A‐M, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta‐analyses. BMJ (Clinical research ed.) 2003;326(7387):472.
Spijker J, de Graaf R, Bijl RV, Beekman AT, Ormel J, Nolen WA. Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). British Journal of Psychiatry: the Journal of Mental Science 2002;181:208‐13.
Spijker J, van Straten A, Bockting C L, Meeuwissen JAC, van Balkom A. Psychotherapy, antidepressants, and their combination for chronic major depressive disorder: a systematic review. Canadian Journal of Psychiatry 2013;58(7):386‐92.
Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self‐report version of PRIME‐MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999;282(18):1737‐44.
Stangier U, Hilling C, Heidenreich T, Risch AK, Barocka A, Schlosser R, et al. Maintenance cognitive‐behavioral therapy and manualized psychoeducation in the treatment of recurrent depression: a multicenter prospective randomized controlled trial. American Journal of Psychiatry 2013;170(6):624‐32.
Sterne JAC, Egger M, Smith GD. Investigating and dealing with publication and other biases in meta‐analysis. BMJ 2001;323(7304):101‐5.
Sterne JAC, Higgins JPT, Reeves BC, on behalf of the development group for ACROBAT‐NRSI. A Cochrane Risk Of Bias Assessment Tool: for Non‐Randomized Studies of Interventions (ACROBAT‐NRSI), Version 1.0.0. Available from http://www.riskofbias.info (accessed 24 June 2015).
Thompson SG, Sharp SJ. Explaining heterogeneity in meta‐analysis: a comparison of methods. Statistics in Medicine 1999;18(20):2693‐708.
Vittengl JR, Clark LA, Dunn TW, Jarrett RB. Reducing relapse and recurrence in unipolar depression: a comparative meta‐analysis of cognitive‐behavioral therapy's effects. Journal of Consulting and Clinical Psychology 2007;75(3):475‐88.
Vittengl JR, Clark LA, Jarrett RB. Continuation‐phase cognitive therapy's effects on remission and recovery from depression. Journal of Consulting and Clinical Psychology 2009;77(2):367‐71.
von Wolff A, Hölzel LP, Westphal A, Härter M, Kriston L. Combination of pharmacotherapy and psychotherapy in the treatment of chronic depression: a systematic review and meta‐analysis. BMC Psychiatry 2012;12:61.
von Wolff A, Hölzel LP, Westphal A, Härter M, Kriston L. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta‐analysis. Journal of Affective Disorders 2013;144(1‐2):7‐15.
World Health Organization. International Classification of Mental and Behavioural Disorders, 10th Revision (ICD‐10). Geneva: World Health Organization, 1992.
World Health Organization. The Global Burden of Disease: 2004 update. Geneva: World Health Organization, 2008.
References to other published versions of this review
Ir a:
von Wolff A, Liebherz S. Comparative effectiveness of Continuation and Maintenance Treatments for Chronic Depression (COMACHRON): a systematic review. PROSPERO 2014:CRD42014009928. Available from www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014009928 (accessed 12 August 2014).
